Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Renal Function in Transfusion-Dependent β-Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes

Osama Tanous, MD, Yossi Azulay, MD, Tal Dujovny, MD, Netta Schwarz, PhD, Raul Colodner, PhD, Ariel Koren, MD, Carina Levin, MDPhD

Blood (2017) 130 (Supplement 1): 949.

https://doi.org/10.1182/blood.V130.Suppl_1.949.949

Published: 2017

Journal Articles

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Nayara Ribeiro Guedes, Juliana Goncalves, MD, Marcelo Lacerda, MD, Maria Cristina Nunez, ANA RITA F B Medeiros, MD, Ana Carolina Kirchmeyer, Andre domingues Pereira, MD, Patricia Eiko Yamakawa, MD, Melca Oliveira Barros, MD PhD, Matheus Vescovi, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2017) 130 (Supplement 1): 4961.

https://doi.org/10.1182/blood.V130.Suppl_1.4961.4961

Published: 2017

Journal Articles

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Benedetta Rambaldi, MD, Michele Malagola, MD PhD, Giuseppe Ravizzola, MD, Giorgio Giannetta, Nicola Polverelli, MD PhDstudent, Cristina Skert, MD, Alessandro Turra, MD, Valeria Cancelli, MD, Federica Cattina, MD PhD, Francesca Schieppati, MD, Arnaldo Caruso, MD, Domenico Russo, MD

Blood (2016) 128 (22): 2223.

https://doi.org/10.1182/blood.V128.22.2223.2223

Published: 2016

Journal Articles

Twice-Weekly Trimethoprim-Sulfamethoxazole for the Prevention of Pneumocystis Jiroveci Pneumonia in Non-Hodgkin Lymphoma Patients

Keiko Ono, MD, Hideki Tsujimura, Takeaki Sugawara, MD PhD, Mikiko Ise, MD PhD, Akiyasu Satou, MD, Xiaofei Wang, MD PhD, Kyoya Kumagai, MD

Blood (2015) 126 (23): 5093.

https://doi.org/10.1182/blood.V126.23.5093.5093

Published: 2015

Journal Articles

Low-Dose FCR Is a Safe and Effective Treatment Option for Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Updated Results of Project Q-Lite By Czech CLL Study Group

Lukas Smolej, MDPhD, Yvona Brychtova, MD PhD, Michael Doubek, Prof., MD PhD, Eduard Cmunt, MDPhD, Martin Spacek, MD, PhD, David Belada, MD, Monika Motyckova, MDPhD, Irena Zygulova, MD, Dagmar Adamova, MD, Vit Prochazka, MDPhD, Martin Simkovic, MD, Katerina Klaskova, MS, Tomas Kozak, MDPhD

Blood (2014) 124 (21): 4670.

https://doi.org/10.1182/blood.V124.21.4670.4670

Published: 2014

Journal Articles

Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Deok-Hwan Yang, MD, PhD, Won Seog Kim, Young-Rok Do, PhD, Sung Yong Oh, Min Kyoung Kim, Yeung-Chul Mun, Ho-Jin Shin, Jae-Yong Kwak, Hye Jin Kang, Jong-Ho Won, MD, PhD, Jung hye Kwon, Hyo Jung Kim, MD, PhD, Cheolwon Suh, Je-Jung Lee, MD, PhD

Blood (2013) 122 (21): 3031.

https://doi.org/10.1182/blood.V122.21.3031.3031

Published: 2013

Journal Articles

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Nathan P Clark, PharmD, FCCP, BCPS, Thomas Delate, PhD, MS, Catherine S Riggs, PharmD, Daniel M Witt, PharmD, FCCP, BCPS, Elaine M Hylek, MD, David A Garcia, MD, Walter Ageno, MD, Francesco Dentali, MD, Mark A. Crowther, MD, MSc, FRCPC

Blood (2013) 122 (21): 1143.

https://doi.org/10.1182/blood.V122.21.1143.1143

Published: 2013

Journal Articles

Phase 2 Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia

Luciano J Costa, MD, PhD, Suzanne Fanning, DO, Joseph Stephenson, MD, Lawrence Afrin, MD, Tricia Bentz, Shanta Salzer, Rachel Whirley, Carlyn Sander, Robert K Stuart, MD

Blood (2012) 120 (21): 3933.

https://doi.org/10.1182/blood.V120.21.3933.3933

Published: 2012

Journal Articles

Primed-G-CSF BMT for Children with Fanconi Anemia (FA) Using Mycophenolate Mofetil (MMF) and Cyclosporine-A for Gvhd Prophylaxis: Rapid Neutrophil Engraftment, Less Mucositis and Low Incidence of Chronic Gvhd

Fabiana Ostronoff, MD, Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Rodolfo Calixto, Monique Martins, Mariana Coutinho, Alexandre Sucupira, Luis Fabio Botelho, Rodrigo Florencio, MD

Blood (2010) 116 (21): 3522.

https://doi.org/10.1182/blood.V116.21.3522.3522

Published: 2010

Journal Articles

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

E. Mauricio Castellanos, M.D., Monika Metzger, L. Fulgencio Baez, Yessica Gamboa, Armando Pena Hernandez, Soad Alabi, Sandra Luna-Fineman, MD, Rosa Nieves, Pedro de Alarcon, MD

Blood (2009) 114 (22): 718.

https://doi.org/10.1182/blood.V114.22.718.718

Published: 2009

Journal Articles

Efficacy and Safety of FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed by Yttrium-90 Ibritumomab Tiuxetan in Relapsed Follicular Lymphoma (FL) Patients

Francesco Pisani, Carlo Ludovico Maini, Rosa Sciuto, Laura Dessanti, Antonio Spadea, Andrea Mengarelli, Mariella D’Andrea, Sandra Rea, Luisa Romano, Maria Concetta Petti

Blood (2008) 112 (11): 5003.

https://doi.org/10.1182/blood.V112.11.5003.5003

Published: 2008

Journal Articles

Maternal Clonal Marrow Stromal Cells Expanded by “Subfractionation Culturing Method” Used for the Treatment of Refractory Chronic Graft Versus Host Disease of an Allogeneic Blood Stem Cell Recipient from an Unrelated Donor.

Chul Soo Kim, MD, PhD, Sun Uck Song, PhD, Moon Hee Lee, MD PhD, Joo Han Lim, MD, Hyeon Gyu Yi, MD, Hyunmin Park, MD, Jin Soo Kim, MD, Hyung Kil Kim, MD PhD

Blood (2007) 110 (11): 4910.

https://doi.org/10.1182/blood.V110.11.4910.4910

Published: 2007

Journal Articles

A Phase I Trial of Subcutaneous (SQ) Dose-Escalated Alemtuzumab in Patients with T-Cell Lymphoproliferative Disorders (T-LPD).

Pierluigi Porcu, MD, Robert A. Baiocchi, MD, Thomas S. Lin, MD, PhD, Kristie A. Blum, MD, Patricia Curtis, RN, Grever R. Michael, MD, John C. Byrd, MD

Blood (2007) 110 (11): 3417.

https://doi.org/10.1182/blood.V110.11.3417.3417

Published: 2007

Journal Articles

Reversal of Complications Following Intensive Combined Chelation in β-Thalassemia Major Patients.

Kallistheni Farmaki, MD, Ioanna Tzoumari, MD, Christina Pappa, MD, Christos Tompoukis, MD, Aggeliki Papagianni, MD, Nikos Aggelopoulos, MD, Demetrios Mitas, MD, Vasilios Berdoukas, MB, BS

Blood (2007) 110 (11): LB4.

https://doi.org/10.1182/blood.V110.11.LB4.lb4

Published: 2007

Journal Articles

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Marina Motta, MD, William Wierda, MD, PhD, Susan O’Brien, MD, Stefan Faderl, MD, Alessandra Ferrajoli, MD, Michelle Detry, PhD, Susan Lerner, MS, Hagop Kantarjian, MD, Michael Keating, MB, BS

Blood (2005) 106 (11): 720.

https://doi.org/10.1182/blood.V106.11.720.720

Published: 2005

NARROW

Renal Function in Transfusion-Dependent β-Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Twice-Weekly Trimethoprim-Sulfamethoxazole for the Prevention of Pneumocystis Jiroveci Pneumonia in Non-Hodgkin Lymphoma Patients

Low-Dose FCR Is a Safe and Effective Treatment Option for Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Updated Results of Project Q-Lite By Czech CLL Study Group

Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Phase 2 Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia

Primed-G-CSF BMT for Children with Fanconi Anemia (FA) Using Mycophenolate Mofetil (MMF) and Cyclosporine-A for Gvhd Prophylaxis: Rapid Neutrophil Engraftment, Less Mucositis and Low Incidence of Chronic Gvhd

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

Efficacy and Safety of FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed by Yttrium-90 Ibritumomab Tiuxetan in Relapsed Follicular Lymphoma (FL) Patients

Maternal Clonal Marrow Stromal Cells Expanded by “Subfractionation Culturing Method” Used for the Treatment of Refractory Chronic Graft Versus Host Disease of an Allogeneic Blood Stem Cell Recipient from an Unrelated Donor.

A Phase I Trial of Subcutaneous (SQ) Dose-Escalated Alemtuzumab in Patients with T-Cell Lymphoproliferative Disorders (T-LPD).

Reversal of Complications Following Intensive Combined Chelation in β-Thalassemia Major Patients.

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only